Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Edit functionality is currently unavailable.

Barry M. Berger, M.D.


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Eckmann JD, Ebner DW, Bering J, Kahn A, Rodriguez E, Devens ME, Lowrie KL, Doering K, Then S, Burger KN, Mahoney DW, Prichard DO, Wallace MB, Gurudu SR, Finney LJ, Limburg P, Berger B, Ahlquist DA, Kisiel JB. Multitarget Stool DNA Screening in Clinical Practice: High Positive Predictive Value for Colorectal Neoplasia Regardless of Exposure to Previous Colonoscopy. Am J Gastroenterol. 2020 04; 115(4):608-615. PMID: 32068535.
  2. Weiser E, Parks PD, Swartz RK, Thomme JV, Lavin PT, Limburg P, Berger BM. Cross-sectional adherence with the multi-target stool DNA test for colorectal cancer screening: Real-world data from a large cohort of older adults. J Med Screen. 2020 Feb 13; 969141320903756. PMID: 32054393.
  3. Berger BM, Kisiel JB, Imperiale TF, Geenen DJ, Heigh RI, Mahoney DW, Hilsden RJ. Low Incidence of Aerodigestive Cancers in Patients With Negative Results From Colonoscopies, Regardless of Findings From Multitarget Stool DNA Tests. Clin Gastroenterol Hepatol. 2020 Apr; 18(4):864-871. PMID: 31394289.
  4. Cooper GS, Markowitz SD, Chen Z, Tuck M, Willis JE, Berger BM, Brenner DE, Li L. Performance of multitarget stool DNA testing in African American patients. Cancer. 2018 10 01; 124(19):3876-3880. PMID: 30193399.
    Citations:    Fields:    
  5. Cooper GS, Markowitz SD, Chen Z, Tuck M, Willis JE, Berger BM, Brenner DE, Li L. Evaluation of Patients with an Apparent False Positive Stool DNA Test: The Role of Repeat Stool DNA Testing. Dig Dis Sci. 2018 06; 63(6):1449-1453. PMID: 29516325.
    Citations:    Fields:    Translation:Humans
  6. Prince M, Lester L, Chiniwala R, Berger B. Multitarget stool DNA tests increases colorectal cancer screening among previously noncompliant Medicare patients. World J Gastroenterol. 2017 Jan 21; 23(3):464-471. PMID: 28210082.
    Citations:    Fields:    Translation:HumansPHPublic Health
  7. Levin TR, Corley DA, Jensen CD, Marks AR, Zhao WK, Zebrowski AM, Quinn VP, Browne LW, Taylor WR, Ahlquist DA, Lidgard GP, Berger BM. Genetic Biomarker Prevalence Is Similar in Fecal Immunochemical Test Positive and Negative Colorectal Cancer Tissue. Dig Dis Sci. 2017 03; 62(3):678-688. PMID: 28044229.
    Citations:    Fields:    Translation:HumansCellsPHPublic Health
  8. Berger BM, Lidgard GP. A Response to Keller's Commentary. Am J Med. 2016 10; 129(10):e235. PMID: 27393107.
    Citations:    Fields:    
  9. Kuntz KM, Zauber AG, Knudsen AB, Rutter CM, Lansdorp-Vogelaar I, Berger BM, Levin B. A restricted look at CRC screening: not considering annual stool testing as an option. Am J Manag Care. 2016 07 01; 22(7):e270-4. PMID: 27442311.
    Citations:    Fields:    
  10. Berger BM, Levin B, Hilsden RJ. Multitarget stool DNA for colorectal cancer screening: A review and commentary on the United States Preventive Services Draft Guidelines. World J Gastrointest Oncol. 2016 May 15; 8(5):450-8. PMID: 27190584.
    Citations: 2     
  11. Berger BM, Parton MA, Levin B. USPSTF colorectal cancer screening guidelines: an extended look at multi-year interval testing. Am J Manag Care. 2016 Feb 01; 22(2):e77-81. PMID: 26881323.
    Citations: 4     Fields:    Translation:Humans
  12. Berger BM, Schroy PC, Dinh TA. Screening for Colorectal Cancer Using a Multitarget Stool DNA Test: Modeling the Effect of the Intertest Interval on Clinical Effectiveness. Clin Colorectal Cancer. 2016 09; 15(3):e65-74. PMID: 26792032.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  13. Imperiale TF, Ransohoff DF, Itzkowitz SH, Levin TR, Lavin P, Lidgard GP, Ahlquist DA, Berger BM. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014 Apr 03; 370(14):1287-97. PMID: 24645800.
    Citations: 201     Fields:    Translation:HumansPHPublic Health
  14. Heigh RI, Yab TC, Taylor WR, Hussain FT, Smyrk TC, Mahoney DW, Domanico MJ, Berger BM, Lidgard GP, Ahlquist DA. Detection of colorectal serrated polyps by stool DNA testing: comparison with fecal immunochemical testing for occult blood (FIT). PLoS One. 2014; 9(1):e85659. PMID: 24465639.
    Citations: 19     Fields:    Translation:HumansPHPublic Health
  15. Lidgard GP, Domanico MJ, Bruinsma JJ, Light J, Gagrat ZD, Oldham-Haltom RL, Fourrier KD, Allawi H, Yab TC, Taylor WR, Simonson JA, Devens M, Heigh RI, Ahlquist DA, Berger BM. Clinical performance of an automated stool DNA assay for detection of colorectal neoplasia. Clin Gastroenterol Hepatol. 2013 Oct; 11(10):1313-8. PMID: 23639600.
    Citations: 35     Fields:    Translation:Humans
  16. McMullen MJ, Woolford SW, Moore CL, Berger BM. Process, cost, and clinical quality: the initial oral contraceptive visit. Am J Manag Care. 2013 Jan 01; 19(1):e14-21. PMID: 23379775.
    Citations:    Fields:    Translation:Humans
  17. Berger BM, Ahlquist DA. Stool DNA screening for colorectal neoplasia: biological and technical basis for high detection rates. Pathology. 2012 Feb; 44(2):80-8. PMID: 22198259.
    Citations: 16     Fields:    Translation:HumansPHPublic Health
  18. Ahlquist DA, Zou H, Domanico M, Mahoney DW, Yab TC, Taylor WR, Butz ML, Thibodeau SN, Rabeneck L, Paszat LF, Kinzler KW, Vogelstein B, Bjerregaard NC, Laurberg S, Sørensen HT, Berger BM, Lidgard GP. Next-generation stool DNA test accurately detects colorectal cancer and large adenomas. Gastroenterology. 2012 Feb; 142(2):248-56; quiz e25-6. PMID: 22062357.
    Citations: 70     Fields:    Translation:Humans
  19. Ahlquist DA, Taylor WR, Mahoney DW, Zou H, Domanico M, Thibodeau SN, Boardman LA, Berger BM, Lidgard GP. The stool DNA test is more accurate than the plasma septin 9 test in detecting colorectal neoplasia. Clin Gastroenterol Hepatol. 2012 Mar; 10(3):272-7.e1. PMID: 22019796.
    Citations: 39     Fields:    Translation:Humans
  20. Moore CL, McMullen MJ, Woolford SW, Berger BM. Clinical process variation: effect on quality and cost of care. Am J Manag Care. 2010 May; 16(5):385-92. PMID: 20469959.
    Citations: 2     Fields:    Translation:Humans
  21. Markowitz SD, Itzkowitz SH, Berger BM. The effectiveness of colonoscopy in reducing mortality from colorectal cancer. Ann Intern Med. 2009 Jun 02; 150(11):816-7; author reply 819-20. PMID: 19487718.
    Citations: 3     Fields:    Translation:Humans
  22. Li D, Jin C, McCulloch C, Kakar S, Berger BM, Imperiale TF, Terdiman JP. Association of large serrated polyps with synchronous advanced colorectal neoplasia. Am J Gastroenterol. 2009 Mar; 104(3):695-702. PMID: 19223889.
    Citations: 31     Fields:    Translation:Humans
  23. Itzkowitz S, Brand R, Jandorf L, Durkee K, Millholland J, Rabeneck L, Schroy PC, Sontag S, Johnson D, Markowitz S, Paszat L, Berger BM. A simplified, noninvasive stool DNA test for colorectal cancer detection. Am J Gastroenterol. 2008 Nov; 103(11):2862-70. PMID: 18759824.
    Citations: 41     Fields:    Translation:Humans
  24. Berger BM, Schroy PC, Rosenberg JL, Lai-Goldman M, Eisenberg M, Brown T, Rochelle RB, Billings PR. Colorectal cancer screening using stool DNA analysis in clinical practice: early clinical experience with respect to patient acceptance and colonoscopic follow-up of abnormal tests. Clin Colorectal Cancer. 2006 Jan; 5(5):338-43. PMID: 16512992.
    Citations: 11     Fields:    Translation:Humans
  25. Berger BM, Robison L, Glickman J. Colon cancer-associated DNA mutations: marker selection for the detection of proximal colon cancer. Diagn Mol Pathol. 2003 Dec; 12(4):187-92. PMID: 14639104.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  26. Berger BM, Vucson BM, Ditelberg JS. Gene mutations in advanced colonic polyps: potential marker selection for stool-based mutated human DNA assays for colon cancer screening. Clin Colorectal Cancer. 2003 Nov; 3(3):180-5. PMID: 14706178.
    Citations: 1     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Berger's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (98)
Co-Authors (3)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.